Revenue for the twelve months ended December 31, 2024, was $4.9 million, compared to $15.5 million for the twelve months ended December 31, 2023, primarily reflecting a decrease in construction ...
Transformational 2024: successfully advanced from preclinical to clinical stage companyStrengthened leadership team to drive growth and advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback